Talkin' Teeth: An Expert Answers Your Questions About Dental Health
These are just a few of the questions you sent to us about dental care — and we've brought in a pro to get you some answers. We've invited Bill Dorfman, DDS, a leading dentist you may recognize from his recurring appearances on The Doctors, to discuss everything from implants, how to banish bad breath, what to look for in a whitening product, and a whole lot more.
Reader Q: What is deep teeth cleaning, and is it worth the extra cost?
Dr. Dorfman: A deep cleaning goes beneath the gumline to remove plaque and tartar that regular cleanings don't typically reach. It's essential if you have signs of periodontal disease (like bone loss or pockets). If your dentist recommends it, it's probably because you need it. Skipping it could mean more bone loss or even eventual tooth loss. Is it worth the cost? 100 percent. It's not cosmetic, it's foundational to your oral health.
Do you recommend using a Waterpik?
I would recommend using a Waterpik if you have braces, bridges, or implants, or if you're prone to gum inflammation — but a Waterpik is not a replacement for flossing. Although it can assist those with mobility issues or get into hard-to-reach places, such as between brace brackets, it won't be able to get between the teeth as well as traditional floss will. So, I'd rather you use a Waterpik than nothing, but flossing is always the best option.
What can I do about my boyfriend's bad breath? He brushes, flosses, and uses a Waterpik two to three times a day. What else can he do?
Even people with excellent oral hygiene can suffer from bad breath. If he's brushing, flossing, and using a Waterpik diligently, it might be time to explore alternative solutions. Bad breath can stem from bacteria on the tongue, tonsil stones, dry mouth, or even gut health. Ninety percent of oral malodor (aka bad breath) comes from the tongue. I recommend that he try a tongue scraper, stay hydrated, and limit his consumption of coffee and alcohol. If the bad breath persists, have him see a dentist to rule out gum disease. It's not always about brushing more; it's about finding the source of the problem and making the necessary changes in his routine to solve it. If all else fails, I'd recommend sugar-free gum or mints.
Should we be concerned about lead in toothpaste? What brands would you recommend?
Yes, unfortunately, some imported or non-FDA-regulated toothpastes have been found to contain trace amounts of heavy metals. Stick with reputable, ADA-approved brands. I also always recommend my patients use fluoridated toothpaste. Personally, I would avoid anything that's not clearly labeled or comes from unknown online sellers. When it comes to what goes in your mouth daily, it's better to be safe than sorry.
The enamel on my teeth has worn down. What can be done?
Once enamel is gone, it doesn't grow back, but we do have solutions. A few options are bonding, veneers, or crowns. All of these can restore the natural look of your teeth and keep them protected. I also recommend you use a low-abrasion toothpaste and avoid acidic drinks. You can also have your dentist evaluate you for tooth grinding. Grinding is a leading cause of enamel wear, and a custom nightguard made by your dentist can help.
What is the best way to whiten teeth at home?
Generally, when seeking an at-home teeth whitening solution, look for a product that contains either hydrogen peroxide or carbamide peroxide. If the product you're looking at doesn't have either of those ingredients, it won't actually whiten your teeth. The most it'll do is remove surface stains, but it won't whiten the structure of your teeth.
We just launched a new tooth whitening strip called POOOF! — now available on Amazon. POOOF! Whitens your teeth 37 percent faster than the leading tooth whitening strip in a 10-day in vitro study. It's also made with a zero-sensitivity formula and tastes great. The strips actually dissolve in 10 to 15 minutes on your teeth, so it's fast, easy, and convenient.
Any advice before I get implants?
Implants are one of the best long-term solutions for missing teeth, but they require some planning:
Have your dentist check that your bone density is sufficient. If not, a bone graft may be needed.
Choose an experienced surgeon and restorative dentist. This is not something you want to bargain-shop for.
After placement, follow all care instructions as advised by your dentist. If done right, implants can last decades, or even a lifetime.
Fluoride — yea or nay?
Yea! Fluoride is proven to prevent cavities and strengthen enamel. If you're at high risk for decay, it's a great preventive tool. If you have fluoridated water, make sure the amount is ideal. Too much is not beneficial. Use fluoridated toothpaste, too. Most adults also benefit from topical fluoride during their regular teeth cleanings. Unless you have a medical contraindication, I would always choose to use fluoride.
The information provided in this article isn't intended as medical advice, and shouldn't replace professional medical treatment. Consult your healthcare provider with any serious health concerns.
The post Talkin' Teeth: An Expert Answers Your Questions About Dental Health appeared first on Katie Couric Media.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
Yahoo
3 hours ago
- Yahoo
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
(Reuters) -Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Forbes
3 hours ago
- Forbes
Sweeping Problems Under The Rug By The Feds Doesn't Make Them Go Away
A man walks his dog past a homeless man sleeping under a message painted on a boarded up shop in San ... More Francisco, California on April, 1, 2020, during the novel coronavirus outbreak. - The US death toll from the coronavirus pandemic topped 5,000 late on April 1, according to a running tally from Johns Hopkins University. (Photo by Josh Edelson / AFP) (Photo by JOSH EDELSON/AFP via Getty Images) For decades, every administration, every Congress, put many things off for someone else to deal with. No one can get everything done all the time, that's understandable. But many current economic and social programs aren't a result of juggling what might be possible. Instead, they have become the ultimate attempt to kick every can down the road. That doesn't solve problems. It only hides them and allows them to grow and fester. One of the current examples is homelessness. Here is a statement out of the presidential executive order, Ending Crime And Disorder On America's Streets: 'The overwhelming majority of these individuals are addicted to drugs, have a mental health condition, or both. Nearly two-thirds of homeless individuals report having regularly used hard drugs like methamphetamines, cocaine, or opioids in their lifetimes. An equally large share of homeless individuals reported suffering from mental health conditions.' Homelessness is a problem in many parts of the country. And, yes, people on the streets are often troubled in one way or another. However, the entire executive order is a rhetorical setup, claiming that 'nearly two-thirds' of the individuals reporting having used 'hard drugs like methamphetamines, cocaine, or opioids in their lifetimes.' No source for the statistic that is then delivered to deemphasize that any such use might have been long before. And then a statement that an 'equally large share of homeless individuals reported suffering from mental health conditions.' No source, again, and no explanation of what mental health conditions mean. Broadly defined enough, like any amount of depression, anxiety, discomfort, and so on, it could include everyone in the country. Next, a combination of claiming that spending by the federal government and states has run tens of billions on failed programs 'that address homelessness but not its root causes.' After claiming that homeless people leave 'other citizens vulnerable to public safety threats' comes the statement, 'Shifting homeless individuals into long-term institutional settings for humane treatment through the appropriate use of civil commitment will restore public order.' After stating that previous spending never looked at root causes, presuming that the administration knows the root causes, the proffered solution is to lock people away. The message is to ignore the problem and put it out of sight. The point isn't really for safety, because most dangerous behavior in the country doesn't come from homeless people. It's for comfort and to pretend everything is fine. This has economic and social implications. Institutionalize where? Privately owned prisons where someone makes a lot of money from incarcerations? Hospitals that have been financially struggling but will even more now that Medicaid has been so thoroughly cut? Similar issues come in arguments over diversity, equity, and inclusion, or DEI. The administration wants it purged not only from websites and government discussions, but from corporations, universities, and anywhere else the term might appear. Again, the communication expressed by action is to strike any mention of the topic anywhere, to bury it from consciousness as though that makes issues go away. It never does. Other parts of life are no different. Corporations want to promote the use of the most recent forms of artificial intelligence. Traditionally, the argument executives would use is not that technology was about enabling job cuts, but to free people up to do more useful and interesting work. That mask has finally begun to slip as CEOs and their corporations boast of shrinking their workforces. Ultimately, this will lead to fewer people being employed, greater degrees of consumer financial struggle, and economic weakness. But, again, that all gets brushed under the carpet. No society can long stand with such undermining. So long as problems are ignored, they likely grow worse until there comes a point that they demand more resources than are available.
